S. Himatlal Healthcare LLP β Soframycin Exporter Profile
Indian Pharmaceutical Exporter Β· #3 for Soframycin Β· $11.4K export value Β· DGFT Verified
S. Himatlal Healthcare LLP is the #3 Indian exporter of Soframycin with $11.4K in export value and 16 verified shipments. S. Himatlal Healthcare LLP holds a 1.9% market share in Soframycin exports across 1 countries. The company exports 5 pharmaceutical products worth $106.4K across 3 therapeutic categories.
S. Himatlal Healthcare LLP β Soframycin Export Profile: Buyers & Destinations

Where Does India Export Soframycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $473.2K | 16 | 79.1% |
| ANGOLA | $70.0K | 2 | 11.7% |
| TANZANIA | $23.4K | 30 | 3.9% |
| SEYCHELLES | $22.7K | 72 | 3.8% |